The antibiotic puzzle: Guidelines for the family physician;Le casse-tete de l'antibiotherapie directives a l'intention du medecin de famile

Canadian Journal of Infectious Diseases

Volumn 8, Issue SUPPL. C, 1997, Pages

  Harding, G ^a   Field, S ^b   MacMahon, R ^b   Louie, T ^b  

^a ST BONIFACE GENERAL HOSPITAL   (Canada)

^b NONE

Author keywords

Antibiotic guidelines; Diabetic foot infections; Family physician; Infection guidelines; Prostatitis; Respiratory tract infections; Urinary tract infections

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIBIOTIC AGENT; AZITHROMYCIN; CEFACLOR; CEFALEXIN; CEFIXIME; CEFOTAXIME; CEFTRIAXONE; CEFUROXIME AXETIL; CEPHALOSPORIN DERIVATIVE; CILASTATIN; CIPROFLOXACIN; CLARITHROMYCIN; COTRIMOXAZOLE; DOXYCYCLINE; ERYTHROMYCIN; GENTAMICIN; IMIPENEM; MACROLIDE; METRONIDAZOLE; NITROFURANTOIN; NORFLOXACIN; OFLOXACIN; PENICILLIN DERIVATIVE; PIPERACILLIN; TAZOBACTAM; TRIMETHOPRIM; UNINDEXED DRUG;

ANTIBIOTIC THERAPY; BACTERIAL INFECTION; BACTERIAL PNEUMONIA; BACTERIURIA; BRONCHITIS; CANADA; CONFERENCE PAPER; CYSTITIS; DIABETIC FOOT; GENERAL PRACTICE; GENERAL PRACTITIONER; HEALTH CARE SYSTEM; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; PRACTICE GUIDELINE; PROSTATITIS; PYELONEPHRITIS; RESPIRATORY TRACT INFECTION; SINUSITIS; URINARY TRACT INFECTION;

EID: 0031415672     PISSN: 11802332     EISSN: None     Source Type: Journal    
DOI: 10.1155/1997/620805     Document Type: Conference Paper

References (69)

1. Evans KL. Diagnosis and management of sinusitis. BMJ 1994;309:1415-22.
2. Van Buchem FL, Knottnerus JA, Schrijnemaekers VJ, Peeters MF. Primary-care-based randomised placebo-controlled trial of antibiotic treatment in acute maxillary sinusitis. Lancet 1997;349:683-7.
3. Axelsson A, Chidekel N, Grebelius N, et al. Treatment of acute maxillary sinusitis: a comparison of four different methods. Acta Otolaryngol 1970;70:71-6.
4. Low DE, Desrosiers M, McSherry J, et al. A practical guide for the diagnosis and treatment of acute sinusitis. Can Med Assoc J 1997;156(Suppl 6):S1-S14.
5. Scriver SR, Walmsley SL, Kau CL, et al. Determination of antimicrobial susceptibilities of Canadian isolates of Haemophilus influenzae and characterization of their beta-lactamases. Antimicrob Agents Chemother 1994;38:1678-80.
6. Baiter MS, Hyland RH, Low DE, et al. Chairs, speakers and participants in the Canadian Bronchitis Symposium. Recommendations on the management of chronic bronchitis. Can Med Assoc J 1994;151(Suppl 10):1-23.
7. Anthonisen NR, Manfreda J, Warren CPW, et al. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med 1987;106:196-204.
8. Mandell LA, Niederman M, the Canadian Community Acquired Pneumonia Consensus Conference Group. Antimicrobial treatment of community acquired pneumonia in adults: a conference report. Can J Infect Dis 1993;4:25-8.
9. Marrie TJ, Durant H, Yates L. Community-acquired pneumonia requiring hospitalization: 5-year prospective study. Rev Infect Dis 1989;11:586-99.
10. MacFarlane JT, Miller AC, Roderick WH, Morris AH, Rose DH. Comparative radiographic features of community acquired legionnaire's disease, pneumococcal pneumonia, mycoplasma pneumonia and psittacosis. Thorax 1984;39:28-33.
11. Mandell LA, Marrie TM, Niederman MS, the Canadian Hospital Acquired Pneumonia Conference Group. Initial antimicrobial treatment of hospital acquired pneumonia in adults: A conference report. Can J Infect Dis 1993;4:317-21.
12. Ronald AR, Nicolle LE, Harding GKM. Standards of therapy for urinary tract infections in adults. Infection 1992;20:S164-70.
13. Ronald AR, Harding GKM. Complicated urinary tract infections. Infect Dis Clin N Am 1997;11:583-92.
14. Norrby SR. Short-term treatment of uncomplicated lower urinary tract infections in women. Rev Infect Dis 1990;12:458-67.
15. Hooton TM, Johnson C, Winter C, et al. Single-dose and three-day regimens of ofloxacin versus trimethoprim-sulfamethoxazole for acute cystitis in women. Antimicrob Agents Chemother 1991;35:1479-83.
16. Saginur R, Nicolle LE, The Canadian Infectious Disease Society Clinical Trials Study Group. Single-dose compared with three days norfloxacin for treatment of uncomplicated urinary infection in women. Arch Intern Med 1992;152:1233-7.
17. Norrby SR. Treatment of urinary tract infections with quinolone antimicrobial agents. In: Hooper DC, Wolfson JS, eds. Quinolone Antimicrobial Agents, 2nd edn. Washington: American Society for Microbiology, 1993.
18. Nicolle LE, DuBois J, Martel AY, Harding GK, Shafran SD, Conly JM. Treatment of uncomplicated urinary tract infections with 3 days lomefloxacin compared with treatment with 3 days of norfloxacin. Antimicrob Agents Chemother 1993;37:574-9.
19. Krieger JN, Ross SO, Simonsen JM. Urinary tract infections in health university men. J Urol 1993;149:1046-8.
20. Barnes RC, Daifuku R, Roddy RE, Stamm WE. Urinary-tract infection in sexually active homosexual men. Lancet 1986;i:171.
21. Nicolle LE, Ronald AR. Recurrent urinary tract infection in adult women: diagnosis and treatment. Infect Dis Clin North Am 1987;1:793.
22. Nicolle LE, Harding GKM, Thompson M, Kennedy J, Urias B, Ronald AR. Efficacy of five years of continuous, low-dose trimethoprim-sulfamethoxazole prophylaxis for urinary tract infections. J Infect Dis 1988;157:1239-42.
23. Harding GKM, Ronald AR. A controlled study of antimicrobial prophylaxis of recurrent infection in women. N Eng J Med 1974;291:597-601.
24. Brumfitt W, Hamilton-Miller JM. Prophylactic antibiotics for recurrent urinary tract infections. J Antimicrob Chem 1990;25:505.
25. Stapleton A, Latham RH, Johnson C, Stamm WE. Post-coital antimicrobial prophylaxis for recurrent urinary tract infection. JAMA 1990;264:703.
26. Pfau A, Sacks T, Engelstein D. Recurrent urinary tract infection in premenopausal women: prophylaxis based on an understanding of the pathogenesis. J Urol 1983;129:1153.
27. Melekos MD, Asbach HW, Gerharz E, Zarakovitis IE, Weingaertner K, Naber KG. Post-intercourse versus daily ciprofloxacin prophylaxis for recurrent urinary tract infections in premenopausal women. J Urol 1997;157:935-9.
28. Wong ES, McKevitt M, Running K, Counts GW, Turck M, Stamm WE. Management of recurrent urinary tract infections with patient-administered single-dose therapy. Ann Intern Med 1985;102:302-7.
29. Hooton TM, Stamm WE. Management of acute uncomplicated urinary tract infection in adults. Med Clin North Am 1991;75:339-57.
30. Pinson AG, Philbrick JT, Lindbeck GH, Schorling JB. Oral antibiotic therapy for acute pyelonephritis: a methodological review of the literature. J Gen Intern Med 1992;7:544-53.
31. Safrin S, Siegel D, Black D. Pyelonephritis in adult women: inpatient versus outpatient therapy. Am J Med 1988;85:793-8.
32. Stamm WE, McKevitt M, Counts GW. Acute renal infection in women: treatment with trimethoprim-sulfamethoxazole or ampicillin for 2 to 6 weeks. A randomized trial. Ann Intern Med 1987;106:341-5.
33. Harding G, Nicolle L, Wenman W, et al. Randomized comparison of oral ciprofloxacin vs standard parenteral therapy in the treatment of complicated urinary tract infections. Drugs 1993;45(Suppl 3):333-4.
34. Childs SJ, Egan RJ. Bacteriuria and urinary infections in the elderly. Urol Clin North Am 1996;23:43-54.
35. Nicolle LE, Mayhew WJ, Bryan L. Prospective randomized comparison of therapy and no therapy for asymptomatic bacteriuria in institutionalized elderly women. Am J Med 1987;83:27-33.
36. Schaeffer AJ. Infections of the urinary tract. In: Walsh PC, Retik AB, Stamey TA, Vaughan, eds. Campbell's Urology, 6th edn. Philadelphia: WB Saunders Company, 1992.
37. Andriole VT, Patterson TF. Epidemiology, natural history, and management of urinary tract infections in pregnancy. Med Clin North Am 1991;75:359-73.
38. Kass EH. Bacteriuria and pyelonephritis of pregnancy. Arch Intern Med 1960;105;194.
39. Harris RE, Gilstrap LC, Pretty A. Single-dose antimicrobial therapy for asymptomatic bacteriuria during pregnancy. Obstet Gynecol 1982;59:546-9.
40. Hooper DC, Wolfson JS. Fluroquinolone antimicrobial agents. N Engl J Med 1991;324:384.
41. Boscia JA, Abrutyn E, Kaye D. Asymptomatic bacteriuria in elderly persons: treat or do not treat? Ann Intern Med 1987;106:764-6.
42. Zhanel GG, Harding GKM, Guay DRP. Asymptomatic bacteriuria. Which patients should be treated? Arch Intern Med 1990;150:1389-96.
43. Harding GKM, Nicolle LE, Ronald AR, et al. How long should catheter-acquired urinary infection in women be treated? A randomized controlled study. Ann Intern Med 1991;114:713-9.
44. Warren JW, Damrom D, Tenney JH, Hoopes JM, Deforge B, Muncie HL Jr. Fever, bacteremia and death as complications of bacteriuria in women with long term urethral catheters. J Infect Dis 1987;155:1151-8.
45. Meares EM. Prostatitis: review of pharmacokinetics and therapy. Rev Infect Dis 1982;4:475-83.
46. Fowler Jr JE. Prostatitis. In: Adult and Pediatric Urology, 3rd edn. Gillenwater JY, Grayhack JT, Howards SS, Duckett W, eds. St Louis: Mosby, 1996.
47. Wolfson JS, Hooper DC. Fluoroquinolone antimicrobial agents. Clin Microbiol Rev 1989;2:378-424.
48. Lawee D, Csima A. Diabetes-related lower extremity amputations in Ontario: 1987-88 experience. Can J Public Health 1992;83:298-302.
49. LoGerfo FW, Coffman JD. Vascular and microvascular disease of the foot in diabetes: Implications for foot care. N Engl J Med 1984;311:1615-9.
50. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-86.
51. Louie TJ, Bartlett JG, Tally FP, Gorbach SL. Aerobic and anaerobic bacteria in diabetic foot ulcers. Ann Intern Med 1976;85:461-3.
52. Caputo GM, Cavanagh PR, Ulbrecht JS, Gibbons GW, Karchmer AW. Assessment and management of foot disease in patients with diabetes. N Engl J Med 1994;331:854-60.
53. Grayson ML, Gibbons GW, Balogh K, Levin E, Karchmer AW. Probing to bone in infected pedal ulcers: A clinical sign of underlying osteomyelitis in diabetic patients. JAMA 1995;273:721-3.
54. Ziment I, Miller LG, Finegold SM. Nonsporulating anaerobic bacteria in osteomyelitis. Antimicrob Agents Chemother 1968;7:77-85.
55. Lipsky BA, Pecoraro RE, Larson SA, Hanley ME, Ahroni JH. Outpatient management of uncomplicated lower extremity infections in diabetic patients. Arch Intern Med 1990;150:790-7.
56. Birke JA, Sims DS. Plantar sensory threshold in the ulcerative foot. Lepr Rev 1986;57:261-7.
57. Sosenko JM, Kato M, Soto R, Bild DE. Comparison of quantitative sensory-threshold measures for their association with foot ulceration in diabetic patients, Diabetes Care 1990;13:1057-61.
58. LoGerfo FW, Gibbons GW, Pomposelli FB, et al. Trends in the care of the diabetic foot: Expanded role of arterial reconstruction. Arch Surg 1992;127:617-20.
59. Gibbons GW, Marcaccio EJ, Burgess AM, et al. Improved quality of diabetic foot care, 1984 vs 1990. Arch Surg 1993;128:576-81.
60. Eckman MH, Greenfield S, MacKey WC, et al. Foot infections in diabetic patients: Decision and cost effective analysis. JAMA 1995;273:712-20.
61. Louie TJ. Intravenous to oral stepdown antibiotic therapy: Another cost-effective strategy in an era of shrinking health care dollars. Can J Infect Dis 1994;5(Suppl C):45C-50C.
62. Bamberger DM, Daus GP, Gerding DN. Osteomyelitis in the feet of diabetic patients: Long term results, prognostic factors, and role of antimicrobial and surgical therapy. Am J Med 1987;83:653-60.
63. Thompson W, Louie TJ, Brunham RC. Duration of antimicrobial therapy for diabetic foot osteomyelitis. Royal College of Physicians and Surgeons of Canada Annual Meeting. Clin Invest Med 1994;17(Suppl A):4. (Abstr)
64. LoGerfo FW, Gibbons GW, Pomposelli FB, et al. Trends in the care of the diabetic foot: Expanded role of arterial reconstruction. Arch Surg 1992;127:617-20.
65. Gibbons GW, Marcaccio EJ, Burgess AM, et al. Improved quality of diabetic foot care, 1984 vs 1990. Arch Surg 1993;128:576-81.
66. Eckman MH, Greenfield S, MacKey WC, et al. Foot infections in diabetic patients: Decision and cost effective analysis. JAMA 1995;273:712-20.
67. Louie TJ. Intravenous to oral stepdown antibiotic therapy: Another cost-effective strategy in an era of shrinking health care dollars. Can J Infect Dis 1994;5(Suppl C):45C-50C.
68. Bamberger DM, Daus GP, Gerding DN. Osteomyelitis in the feet of diabetic patients: Long term results, prognostic factors, and role of antimicrobial and surgical therapy. Am J Med 1987;83:653-60.
69. Thompson W, Louie TJ, Brunham RC. Duration of antimicrobial therapy for diabetic foot osteomyelitis. Royal College of Physicians and Surgeons of Canada Annual Meeting. Clin Invest Med 1994;17(Suppl A):4. (Abstr)